Verastem, Inc. (LON:0LOV)
5.97
-0.23 (-3.71%)
Feb 12, 2026, 4:19 PM GMT
Verastem Employees
Verastem had 78 employees as of December 31, 2024. The number of employees increased by 5 or 6.85% compared to the previous year.
Employees
78
Change (1Y)
5
Growth (1Y)
6.85%
Revenue / Employee
127.60K GBP
Profits / Employee
-2.30M GBP
Market Cap
330.89M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 78 | 5 | 6.85% |
| Dec 31, 2023 | 73 | 16 | 28.07% |
| Dec 31, 2022 | 57 | 9 | 18.75% |
| Dec 31, 2021 | 48 | 0 | - |
| Dec 31, 2020 | 48 | -87 | -64.44% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| AstraZeneca | 94,300 |
| GSK plc | 68,629 |
| Haleon | 24,561 |
| Smith & Nephew | 17,000 |
| Integrated Diagnostics Holdings | 6,309 |
| Advanced Medical Solutions Group | 1,500 |
| Craneware | 765 |
| Tristel | 267 |
Verastem News
- 7 days ago - Verastem Inc (VSTM) CEO Dan Paterson Sells 970 Shares - GuruFocus
- 8 days ago - Verastem (VSTM) Makes Strides with Innovative Cancer Treatments - GuruFocus
- 8 days ago - Verastem posts preliminary 2025 revenue, plans clinical updates in 2026 - Seeking Alpha
- 8 days ago - Verastem Oncology Provides Preliminary Fourth Quarter and 2025 Revenue and Business Updates and Outlines 2026 Strategic Priorities for Novel Portfolio Targeting RAS/MAPK Pathway-Driven Cancers - Business Wire
- 4 weeks ago - Insider Sell: Dan Paterson Sells Shares of Verastem Inc (VSTM) - GuruFocus
- 4 weeks ago - Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 4 weeks ago - Polar Capital Holdings Plc Increases Stake in Verastem Inc - GuruFocus
- 6 weeks ago - Verastem: Downgrading To Buy Based On RAMP-203 Setback In Targeting KRAS G12C NSCLC - Seeking Alpha